About Emerald Therapeutics
Emerald Therapeutics is a company based in San Francisco (United States) founded in 2010 by D J Kleinbaum and Brian Frezza.. Emerald Therapeutics has raised $39.5 million across 4 funding rounds from investors including SciFi VC, Founders Fund and Schooner Capital. The company has 77 employees as of December 31, 2022. Emerald Therapeutics operates in a competitive market with competitors including Waters Corporation, Quartzy, Tecan, Synthace and Automata, among others.
- Headquarter San Francisco, United States
- Employees 77 as on 31 Dec, 2022
- Founders D J Kleinbaum, Brian Frezza
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Emerald Therapeutics
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$39.5 M (USD)
in 4 rounds
-
Latest Funding Round
$20 M (USD), Series C
Jun 01, 2015
-
Investors
SciFi VC
& 3 more
-
Employee Count
77
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Emerald Therapeutics
Emerald Therapeutics has successfully raised a total of $39.5M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $20 million completed in June 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series C — $20.0M
-
First Round
First Round
(22 Dec 2010)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2015 | Amount | Series C - Emerald Therapeutics | Valuation |
investors |
|
| Feb, 2014 | Amount | Series B - Emerald Therapeutics | Valuation | Founders Fund , Max Levchin | |
| Mar, 2012 | Amount | Series A - Emerald Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Emerald Therapeutics
Emerald Therapeutics has secured backing from 4 investors, including venture fund and angel investors. Prominent investors backing the company include SciFi VC, Founders Fund and Schooner Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are directed toward early-stage consumer-tech startups.
|
Founded Year | Domain | Location | |
|
Venture capital investments in technology and defense sectors.
|
Founded Year | Domain | Location | |
|
Private equity investments are directed across multiple sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Emerald Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Emerald Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Emerald Therapeutics Comparisons
Competitors of Emerald Therapeutics
Emerald Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Waters Corporation, Quartzy, Tecan, Synthace and Automata, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of laboratory management system for researchers and clinicians
|
|
| domain | founded_year | HQ Location |
Lab management platform for life sciences is offered by Quartzy.
|
|
| domain | founded_year | HQ Location |
Automated laboratory instruments, robotics, and diagnostic solutions are provided.
|
|
| domain | founded_year | HQ Location |
SaaS-based laboratory automation software is provided for researchers.
|
|
| domain | founded_year | HQ Location |
Lab automation robots are provided for life sciences applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Emerald Therapeutics
Frequently Asked Questions about Emerald Therapeutics
When was Emerald Therapeutics founded?
Emerald Therapeutics was founded in 2010.
Where is Emerald Therapeutics located?
Emerald Therapeutics is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Who is the current CEO of Emerald Therapeutics?
D J Kleinbaum is the current CEO of Emerald Therapeutics. They have also founded this company.
Is Emerald Therapeutics a funded company?
Emerald Therapeutics is a funded company, having raised a total of $39.5M across 4 funding rounds to date. The company's 1st funding round was a Series A of $1M, raised on Dec 22, 2010.
How many employees does Emerald Therapeutics have?
As of Dec 31, 2022, the latest employee count at Emerald Therapeutics is 77.
What does Emerald Therapeutics do?
Emerald Therapeutics was founded in 2010 in San Francisco, United States, focusing on the life sciences sector. Cloud-based software enables remote access to laboratories via the internet. Automated robotics handle experiment conduction, method design, materials logistics, sample preparation, instrument operation, data acquisition and analysis, troubleshooting, and waste disposal. Operations support research workflows in a distributed manner.
Who are the top competitors of Emerald Therapeutics?
Emerald Therapeutics's top competitors include Tecan, Waters Corporation and Automata.
Who are Emerald Therapeutics's investors?
Emerald Therapeutics has 4 investors. Key investors include SciFi VC, Founders Fund, Schooner Capital, and Max Levchin.